BOSTON–(BUSINESS WIRE)–Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the “Company”), an innovation-driven leader in the hydrogen and fuel cell technology space, proudly announces that Dr. Panoraia ‘Nora’ Gourdoupi has agreed to join its board of directors.
Dr. Gourdoupi is Senior Vice President of Corporate Business Development for Advent and has been with Advent since its inception, joining the Company in 2006 as a Senior Scientist. He is intimately involved both in developing the polymers that form the heart of the Company’s fuel cell and MEA products, and in acting as a vital liaison to government and industry partners. Dr. Gourdoupi has a Bachelor of Science in Chemistry and a Ph.D. from the University of Patras, specializing in the synthesis and characterization of polymers for fuel cell applications. She is a co-inventor on eighteen patents in the field.
“Without Nora’s innovation and dedication to our technology, we wouldn’t have a best-in-class MEA powering a portfolio of fuel cell products poised to revolutionize the way power is created,” said Dr. Vasilis Gregoriou, Director executive and president of Advent. “Without his tireless advocacy and diligence in working with the European Commission over the past eighteen months, Advent would not have received approval and ratification for Green HiPo, a colossal project that will transform the Company and ensure that Advent is positioned among the world leaders in technology. of green energy. I welcome you to the board.”
“My entire professional career has been dedicated to developing efficient and cost-effective fuel cells to create clean energy,” said Dr. Gourdoupi. “From my start with the company more than fifteen years ago as a senior scientist to now joining its board of directors, I have always known that Advent’s world-class technology and world-class team will drive the green energy revolution. With the Green HiPo project approved and ratified, the widespread adoption of fuel cells as a truly viable fossil fuel alternative is closer than ever.”
Dr. Gourdoupi will assume the remainder of Dr. Christos Kaskavelis’ Class III term as director. Dr. Kaskavelis resigned from the Advent board on July 19, 2022. He will remain with the company as chief marketing officer. Dr. Kaskavelis stated: “With Nora guiding the approval and ratification of Green HiPo, I am delighted that she is now joining our board of directors. I have known Nora for many years and cannot imagine any other potential board member who could combine her scientific acumen with her demonstrated dedication to the Company. I look forward to fully concentrating on my role as an executive at Advent, and welcome the opportunity to help Nora in any way possible when she joins the board.”
Sponsored Content: OurLifeStore.com is a veteran-owned e-commerce with over 40,000 items at great prices and always free shipping
About Advent Technologies Holdings, Inc.
Advent Technologies Holdings, Inc. is an American corporation that develops, manufactures and assembles complete fuel cell systems, as well as supplies customers with critical fuel cell components in the renewable energy sector. Advent is headquartered in Boston, Massachusetts, with offices in California, Greece, Denmark, Germany, and the Philippines. With more than 150 issued, pending, and licensed patents for fuel cell technology, Advent owns the intellectual property for next-generation HT-PEM that enables multiple fuels to operate at high temperatures and in extreme conditions: offering a flexible “Any fuel. Anywhere.” option for the automotive, aviation, defense, oil and gas, marine and power generation industries. For more information visit www.advent.energy.
Cautionary Note Regarding Forward-Looking Statements
East Press release includes forward-looking statements. These forward-looking statements can generally be identified by the use of words such as “anticipate”, “expect”, “plan”, “could”, “may”, “will”, “believe”, “estimate”, “forecast”. ”, “objective”, “project” and other words of similar meaning. Each forward-looking statement contained in this Press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by any such statement. Applicable risks and uncertainties include, among others, the Company’s ability to maintain the trading price of the Company’s common shares. Values on Nasdaq; future financial performance; potential liquidity and trading of public securities; impact of the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of income growth and properly plan your expenses; expectations regarding future expenses; future combination of income and effect on gross margins; attraction and retention of qualified directors, officers, employees and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance Advent’s corporate reputation and brand; expectations regarding your relationships and actions with technology partners and other third parties; impact of future regulatory, judicial and legislative changes in the industry; ability to locate and acquire complementary technologies or services and integrate them into the Company’s business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies around the world in the industries in which the Company will operate; and the risks identified under the heading “Risk Factors” in Advent’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022, as well as the other information presented before the SEC. Investors are cautioned not to place substantial reliance on the forward-looking statements contained in this press release. We encourage you to read Advent’s SEC filings, available at www.sec.gov, for a discussion of these and other risks and uncertainties. Forward-looking statements in this press release speak only as of the date hereof, and the Company undertakes no obligation to update or revise any of these statements. Advent’s business is subject to material risks and uncertainties, including those listed above. Investors, potential investors and others should carefully consider these risks and uncertainties.
Elisabeth Maragoula/Michael Trontzos
Advent Technologies Holdings, Inc.